CN110117608A - Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening - Google Patents

Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening Download PDF

Info

Publication number
CN110117608A
CN110117608A CN201910229594.6A CN201910229594A CN110117608A CN 110117608 A CN110117608 A CN 110117608A CN 201910229594 A CN201910229594 A CN 201910229594A CN 110117608 A CN110117608 A CN 110117608A
Authority
CN
China
Prior art keywords
gene
sequence
plasmid
ala
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910229594.6A
Other languages
Chinese (zh)
Inventor
曹罡
陈西
穆罕默德·贾迈勒
凯斯塔·拉赫曼
徐伟泽
周伟
杨冰
雷莹莹
曹晓建
林达
傅振芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong Agricultural University
Original Assignee
Huazhong Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong Agricultural University filed Critical Huazhong Agricultural University
Priority to CN201910229594.6A priority Critical patent/CN110117608A/en
Publication of CN110117608A publication Critical patent/CN110117608A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Field the present invention relates to prokaryotes endogenous gene as application tool, more particularly to a kind of application of endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening, wherein, the amino acid sequence of endogenous Rv2823c coding albumen is as shown in SEQ ID No.1;The nucleotide sequence of endogenous Rv2823c gene is as shown in SEQ ID No.2.The present invention, which imports the plasmid pMV-gRNA-HDR built in tubercle bacillus, can be realized insertion, knockout or the interference of gene and the screening of mutant library.Compared with bacteriophage or swivel base submethod, the interference of growth indispensable gene is more optimizedly may be implemented in editor while this method can fast implement single or multiple gene.

Description

Endogenous Rv2823c coding albumen is in tubercle bacillus gene insertion, knockout, interference and dashes forward Application in Mutant libraries screening
Technical field
Field the present invention relates to prokaryotes endogenous gene as application tool, and in particular to a kind of endogenous Rv2823c encodes application of the albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening.
Background technique
According to the latest report of the World Health Organization (World Health Organization, WHO), by tubercle bacillus Tuberculosis caused by (Mycobacterium tuberculosis, abbreviation Mtb) infects is one of big cause of the death in the whole world ten, Newly-increased 1,040,000 people of tuberculosis patient in the whole world in 2016,140,000 people die of the disease.Tuberculosis death more than 95% occurs low Income and middle income country, China are also one of pathogenetic major country of tuberculosis.Due to the unreasonable use of antibiotic Etc. reasons, cause the appearance of multi-drug resistant and extensive drug resistance tubercle bacillus bacterial strain, this brings great challenge for the prevention and treatment of the disease. Termination strategy lungy has been issued in the whole world, but BCG vaccine used at present becomes increasingly preventive effect lungy It is unobvious, therefore there is an urgent need to develop novel attenuated vaccines.Parsing to tubercle bacillus gene function and its pathogenic molecular mechanism It is most important to excavation newtype drug target spot and Vaccine candidate gene.
It is had disadvantages that however, currently used Phage Infection method knocks out tubercle bacillus virulence gene tool, such as efficiency It is low, the period is long, some growths must the knockout of gene cannot achieve, need novel genetic manipulation tool to carry out tuberculosis point The knockout and silencing of branch bacillus virulence gene.
Summary of the invention
It is an object of the invention to overcome the deficiencies of the prior art and provide a kind of endogenous Rv2823c coding albumen to tie The application in gene insertion, knockout, interference and growth indispensable gene mutant library screening is carried out in core bacillus.The present invention Analysis finds that the protein of Rv2823c coding has the function of genetic modification, which, which plays a role, only needs to provide guidance Sequence can realize that insertion, knockout, interference and the screening in gene mutation body library of gene (only need to import gRNA Realize the editor of gene).This method is inserted into inactivation technique, and the party much higher than traditional transposons to the editorial efficiency of gene Method can also realize the purpose for killing bacterium, bring hope for the research and development of tuberculosis novel method for the treatment of.Endogenous nucleic acid has Very high transformation efficiency and genetic modification efficiency.
To achieve the above object, a kind of endogenous Rv2823c coding albumen designed by the present invention carries out base in tubercle bacillus Because of the application in insertion, knockout or interference and growth indispensable gene mutant library screening, wherein endogenous Rv2823c coding The amino acid sequence of albumen is as shown in SEQ ID No.1;The nucleotide sequence of endogenous Rv2823c gene such as SEQ ID No.2 institute Show.
Further, the insertion, the gene for knocking out or interfering are any one or more in the genome of tubercle bacillus Gene.
Still further, the gene is growth indispensable gene.The tubercle bacillus is tubercle bacillus H37Rv, gene All sequences, which disclose in NCBI, in group sees NCBI tubercle bacillus gene (https: //www.ncbi.nlm.nih.gov/ Genome/166? genome_assembly_id=159 857).
The present invention also provides a kind of suitable for gene insertion, the recombinant plasmid of knockout or interference editting function, the matter Intragranular contains the boot sequence of more than one and tubercle bacillus target gene interactionx, x 1,2,3,4 ...;Wherein, boot sequencex For the nucleotide sequence for arbitrarily choosing 40bp in target-gene sequence.
The recombinant plasmid library that the present invention also provides a kind of suitable for growing the screening of indispensable gene mutant library, institute State N number of plasmid in plasmid library, the boot sequence containing 5658 with tubercle bacillus target gene interaction in all plasmidsx, x is 1,2,3,4……;Wherein, boot sequence is the nucleotide sequence of any 40bp on target gene coding strand.
Suitable for autogene insertion, the building method for the recombinant plasmid for knocking out or interfering editting function, feature exists In: the following steps are included:
1) repetitive sequence is designed, wherein repetitive sequence repeat is tcgtcagacccaaaaccccgagaggggacgg Aaac,
2) complex sequences repeat is aggravated at the both ends restriction enzyme site BbsI, synthesis obtains sequence repeat-BbsI-repeat;
3) repeat-BbsI-repeat is inserted into plasmid pMV-261 using the strategy of homologous recombination, that is, forms pMV- 261-crRNA (Fig. 1);
4) using the DNA sequence dna of any one gene in tubercle bacillus gene group as template, select length for 40bp's respectively Boot sequence x;
5) single-stranded boot sequence is made to become double-strand by Gradient annealing,
6) it will be inserted into pMV261 plasmid after the BbsI digestion of double-strand boot sequence, obtain pMV261-gRNA;
It 7) is stencil design upstream and downstream homology arm according to target gene upstream and downstream gene, for the ease of screening, specificity insertion EGFP obtains upstream homology arm -- the downstream EGFP-- homology arm sequence (HDR);Sequence HDR is by the terminator of upstream homology arm It is removed with the promoter of EGFP, becomes an ORF;
8) pMV261-gRNA is subjected to digestion with PstI, then connected, form pMV-gRNA-HDR;
9) above-mentioned connection product is converted into stable3 infection state cell, extracts plasmid pMV-gRNA-HDR, then Sequencing identification;Obtain recombinant plasmid pMV-gRNA-HDR.
It is answered in building insertion, the bacterial strain for knocking out or interfering editor's gene using above-mentioned recombinant plasmid pMV-gRNA-HDR With.
It must be sieved with dispensable gene mutant library using above-mentioned recombinant plasmid library suitable for growth of bacillus tubercle Choose application.
Beneficial effects of the present invention:
The plasmid pMV-gRNA-HDR that the present invention only needs to build, which is imported, can be realized inserting for gene in tubercle bacillus Enter, knock out or interfere and the screening of mutant library.Compared with bacteriophage or swivel base submethod, this method can be quick The interference of growth indispensable gene more optimizedly may be implemented in editor while realizing single or multiple gene.
Detailed description of the invention
Fig. 1 is pMV261-crRNA map;
Fig. 2 is relative position of two Repeats and BbsI in plasmid;
Fig. 3 is the fluorescence microscope detection, PCR detection and sequencing result of gene insertion;
Fig. 4 is the fluorescence microscope detection, PCR detection and sequencing result of gene delection;
Fig. 5 is the qPCR verification result of polygenes RNA interference;
Fig. 6 is mutant library the selection result.
Specific embodiment
The present invention is described in further detail combined with specific embodiments below, so as to those skilled in the art understand that.
Embodiment 1 realizes the insertion (gyrA gene) of tubercle bacillus gene using endogenous Rv2823c coding albumen
1. being suitable for the building method of the plasmid of autogene insertion, comprising the following steps:
1) according to the DNA sequence dna of gyrA gene (see NCBI tubercle bacillus gene https: // Www.ncbi.nlm.nih.gov/gene/887105), the gene order of 40bp: (GTCTGGTCTGCGCCGTTGGCG is selected TCCACGGCATTATCGTCGC), as spacer.
2) according to existing document report, the repeat sequence (gtcgtcagacccaaaaccccgagag of 36bp is selected Gggacggaaac it), and among two repeats is inserted into a BbsI restriction enzyme site (repeat-BbsI-repeat), it will The sequence is sent to Nanjing Genscript Biotechnology Co., Ltd.'s synthesis.
Relative position of two Repeats and BbsI in plasmid as shown in Fig. 2,
3) to carry out digestion actual conditions to plasmid with BbsI as follows:
Reaction system
37 DEG C of effect 2h.
4) single-stranded gRNA is made to become double-strand by Gradient annealing, actual conditions are as follows:
Reaction system
37 DEG C of 30min, 95 DEG C of 5min, then by the gradient cooling of 5 DEG C/min to 25 DEG C.Finally by double-strand oligo 200 times of dilution for connecting reaction.
Double-strand gRNA is such as
5) gRNA is inserted into pMV261 plasmid, actual conditions are as follows:
Linked system
16 DEG C of incubation 1-2h.
6) in order to be inserted into EGFP, therefore upstream and downstream homology arm (upstream homology arm -- the downstream EGFP-- of 400bp is devised Homology arm).Meanwhile removing the promoter of the terminator of upstream homology arm and EGFP, become an ORF.
7) above-mentioned connection product is converted into stable3 infection state cell, extracts plasmid (pMV-gRNA-gyrA- EGFP), then sequencing identification.
2. utilizing the screening of plasmid pMV-gRNA-gyrA-EGFP gene insertion tubercle bacillus strain
1) 0.5 μ g is taken to identify the tubercle bacillus H37Ra of correct recombinant plasmid pMV-gRNA-gyrA-EGFP and 200 μ l Competent cell ice bath 10min.
2) competent cell containing recombinant plasmid is transferred in 0.2 centimetre of sterile electric revolving cup.
3) electroporation GenePulser Xcell (BIO-RAD) parameter is set as 2.5kV, 25 μ F, 1000 Ω.
4) when hearing a sound of " drop ", illustrate that electricity changes into function, be immediately transferred to the competent cell after electric shock newly Sterile EP tube.
5) the 7H9 culture medium containing 10%OADC, 0.02%Tween 80 and 0.5% glycerol of addition 1ml preheating is to the electricity In revolving cup.
6) for 24 hours by the cell incubation in step 5.
7) the cell 3000rpm in step 6 is centrifuged 10min, inhales and abandons supernatant.
8) bacterial sediment is resuspended with 100 μ l fresh cultures, and is coated with the 7H10 plate for containing kanamycins (50 μ g/ μ l) It is grown to single colonie.
9) Olympus IX73 fluorescence microscope is observed.
As shown in Fig. 2, having converted the bacterium colony of the plasmid containing gRNA under fluorescence microscope it can be seen that apparent green is glimmering Light, and control plasmid then can't see green fluorescence, illustrate that EGFP is successfully plugged into bacterial genomes.
3. being sequenced and analyzing
1) the positive bacterium solution of identification is taken into 10 μ l, and boils 5min, to crack bacterium.
2) 1 μ l sample is taken to carry out PCR amplification as template.It is specific as follows:
Reaction system
Reaction condition
Primer information
3) PCR product of 5 μ l is taken to carry out agarose gel electrophoresis.Fluorescent positive clone detects 1.8kb's as the result is shown Band, and control group is then without corresponding band (Fig. 3 B).
4) taking the identification of 40 μ l previous steps, correctly positive PCR product send Wuhan Qing Ke biotechnology company to be sequenced, to slotting Enter gene to be verified.Egfp gene is inserted in the end of gyrA gene as the result is shown, illustrates that egfp gene is successfully plugged into In tubercle bacillus gene group (Fig. 3 C).
Embodiment 2 realizes that tubercle bacillus gene knocks out (by taking esxQ as an example) using endogenous Rv2823c coding albumen
1. being suitable for the building method for the recombinant plasmid that autogene knocks out, comprising the following steps:
1) according to the DNA sequence dna of esxQ gene (see NCBI tubercle bacillus gene https: // Www.ncbi.nlm.nih.gov/gene/888508), the gene order (CACCAGCCGGTCCGAAACGTCG of 40bp is selected GGTGATTGGTTGACGGCT), as spacer.
2) according to existing document report, the repeat sequence (gtcgtcagacccaaaaccccgagag of 36bp is selected Gggacggaaac it), and among two repeats is inserted into a BbsI restriction enzyme site (repeat-BbsI-repeat), it will The sequence is sent to Nanjing Genscript Biotechnology Co., Ltd.'s synthesis.
3) digestion is carried out to plasmid with BbsI, specific as follows:
Reaction system
37 DEG C of effect 2h.
4) single-stranded gRNA is made to become double-strand by Gradient annealing, actual conditions are as follows:
Reaction system
37 DEG C of 30min, 95 DEG C of 5min, then by the gradient cooling of 5 DEG C/min to 25 DEG C.Finally by double-strand oligo 200 times of dilution for connecting reaction.
5) gRNA is inserted into pMV261 plasmid, actual conditions are as follows:
Linked system
16 DEG C of incubation 1-2h.
6) for screening-gene knock-out bacterial strain, we replace target gene with BFP, therefore devise the upstream and downstream of 400bp Homology arm (upstream homology arm -- the downstream BFP-- homology arm).
7) above-mentioned connection product is converted into stable3 infection state cell, and carries out bacterium solution PCR identification.Specifically such as Under:
Reaction system
Primer is from plasmid backbone, for detecting HDR, to avoid the amplification gene from genome.Primer sequence is such as Under:
Reaction condition
8) it extracts PCR and identifies correct recombinant plasmid (pMV-gRNA-esxQ-BFP), further sequencing detection.
2. utilizing the screening of plasmid pMV-gRNA-esxQ-BFP gene knockout tubercle bacillus strain
Detailed in Example 1
3. being sequenced and analyzing
1) the positive bacterium solution of identification is taken into 10 μ l, and boils 5min, to crack bacterium.
2) 1 μ l sample is taken to carry out PCR amplification as template.It is specific as follows:
Reaction system
Reaction condition
Primer information
3) 50 μ l PCR products is taken to carry out agarose gel electrophoresis.Fluorescent positive clone detects 1.6kb's as the result is shown Band, and control group then detects the band (Fig. 4 B) of 1.4kb.
4) it send Wuhan Qing Ke biotechnology company to be sequenced after purification positive PCR product, is verified to gene is knocked out. Bfp gene replacement esxQ gene (Fig. 4 C) as the result is shown.
4.DNA library construction, sequencing and analysis
1) picking wild strain, mutant strain and plasmid control bacterial strain single bacterium fall in 7H9 culture medium and cultivate to OD600nm It is 1.0.
2) 6000rpm is centrifuged 15min and collects bacterial sediment.
3) bacterial sediment is resuspended in the TE buffer of 1ml.
4) it adds the SDS (1%) of 1ml and is incubated for 10min.
5) 100 μ l Proteinase Ks, 55 DEG C of incubation 3h are added.
6) RNase (Roche, Mannheim, Germany) of 100 μ l DNase-free, 37 DEG C of overnight incubations are added.
7) it adds 1mL phenol/chloroform/isoamyl alcohol (25:24:1) and cracks bacterium, 13000rpm is centrifuged 15min.
8) step 7) is repeated three times.
9) supernatant is transferred in a new centrifuge tube.
10) the 3M sodium acetate (pH=5.2) of 0.1 times of volume is added.
11) 100% ethyl alcohol for adding proper volume becomes 80% ethyl alcohol.
12) 13000rpm centrifugation 15min, 4 DEG C.
13) 80% ethanol washing DNA is precipitated three times, each 30s.
14) DNA is resuspended without DNA enzymatic water, and measures its concentration.
15) library is constructed using Nextera Illumina kit.Fragmentation processing, 55 DEG C of works are carried out to DNA with Tn5 Use 30min.It is specific as follows:
16) DNA of fragmentation is attached in different connectors, joint information is as follows:
17) KAPA HiFi archaeal dna polymerase is expanded, specific as follows:
Reaction system
Reaction condition
18) Ampure XP beads is only praised using Nanjing promise to purify library.
19) HiSeq 2000paired-ended (2x 151bp) technology carries out deep sequencing.
20) sequencing result is shown, compared with wild strain, mutant strain has lacked esxQ gene, illustrates successful knockout esxQ Gene (Fig. 4 D and E).
Embodiment 3 realizes that polygenic interference (is with katG, inhA and lpqE gene using Rv2823c coding albumen Example)
1. being suitable for the building method of the recombinant plasmid of autogene interference, comprising the following steps:
1) according to katG, inhA and lpqE gene (see NCBI tubercle bacillus gene
https://www.ncbi.nlm.nih.gov/gene/885638;
https://www.ncbi.nlm.nih.gov/gene/886523;
Https: //www.ncbi.nlm.nih.gov/gene/887254) non-coding sequence finds motif (5 '- GAAAC-3 '), the gene order of motif downstream 40bp, as guide sequence (spacer).
gatG:TGTTGTCCCATTTCGTCGGGGTGTTCGTCCATACGACCTC inhA:
GCGATCGACGAGTCGGTGATGATTCCGCTAACCAGAATCC lpqE:
GTCGGGTGATTGGTTGACGGCTACCAGCACCAGATCCACC
2) repetitive sequence (repeats) that a upper 36bp is added at the both ends spacer, then by repeats- Spacer-repeats-spacer-repeats-spacer-repeats sends to Wuhan Qing Ke biotech company and is synthesized (lpqE-katG-ihnA-gRNA)。
3) digestion is carried out to pMV-261 plasmid with BbsI, specific as follows:
Reaction system
37 DEG C of effect 2h.
4) single-stranded lpqE-katG-ihnA-gRNA is made to become double-strand by Gradient annealing, actual conditions are as follows:
Reaction system
37 DEG C of 30min, 95 DEG C of 5min, then by the gradient cooling of 5 DEG C/min to 25 DEG C.Finally by double-strand oligo 200 times of dilution for connecting reaction.5) lpqE-katG-ihnA-gRNA is inserted into pMV261 plasmid, actual conditions are as follows:
Linked system
16 DEG C of incubation 1-2h.
6) for screening-gene knock-out bacterial strain, we replace target gene with BFP, therefore devise the upstream and downstream of 400bp Homology arm (upstream homology arm -- the downstream BFP-- homology arm).
7) above-mentioned connection product is converted into stable3 infection state cell, and carries out bacterium solution PCR identification.Specifically such as Under:
Reaction system
Reaction condition
8) it extracts PCR and identifies correct recombinant plasmid (pMV-gRNA-katG), further sequencing detection.
Verifying of the 3.qPCR to related gene low expression
1) it chooses positive, plasmid control and wild-type bacterium single bacterium falls in 7H9 culture medium (10ml) and cultivates to OD600nm It is 1.0.
2) 3000rpm is centrifuged 10min and collects bacterial sediment and freeze in -80 DEG C.
3) bacterial sediment is transferred in mortar, and adds appropriate liquid nitrogen, grind 2min to destroy cell wall.
4) bacterial chip is transferred in the EP pipe of no RNA enzyme and adds 1mlTrizol.
5) it adds in appropriate Lysing Matrix B (MP USA) to the pipe.
6) 6000rpm vortex 1min is further crushed bacterium.
7) 200 μ l chloroforms of addition into bacterial lysate and are vortexed 30 seconds.
8) 12000rpm takes the aqueous phase solution of 400 μ l into new EP pipe after being centrifuged 15min.
9) isopropanol and the mixing of 400 μ l are added, incubation at room temperature 10min precipitates RNA.
10) 13000rpm is centrifuged 30min.
11) 80% ethanol washing RNA precipitate of fresh configuration three times, 30 seconds every time.
12) 13000rpm, which is centrifuged to inhale as far as possible after 5min, abandons residual ethanol.
13) RNA is resuspended in 20 μ l nuclease-free waters after being air-dried 10min.
14) genomic DNA remaining with the removal of TURBO DNA-free kit.It is specific as follows:
Reaction system
It mixes gently, is incubated for 30min.Add the DNase Inactivation Reagent room temperature effect of 0.1 times of volume RNA is transferred in new EP pipe after 5min, 10000rpm centrifugation 1.5min.
16) after Nanodrop measures RNA concentration, adjustment RNA concentration is 100ngRNA
17) RNA is inverted to cDNA.It is specific as follows:
Reaction system
18) PerfeCTaSYBR green Supermix applied Biosystems 7300real time PCR is used System carries out relative quantification detection to katG, inhA and lpqE gene.It is specific as follows:
Reaction system
Reaction condition
Primer information
PMV-lpqE-katG-inhA-gRNA plasmid turns Gization C group GlpqE, katG and inhA expression quantity point as the result is shown Do not decline, and there is significant difference (Fig. 5) compared with the control group.
Embodiment 4 realizes the screening in gene mutation body library using Rv2823c coding albumen
The synthesis of 1.gRNA plasmid library
1) according to the sequence information of tubercle bacillus H37Rv genome (https: //www.ncbi.nlm.nih.gov/ Genome/166? genome_assembly_id=159 857), design is directed to the gRNA of 5658 tubercle bacillus genes and send It is synthesized toward company.Designed gRNA is inserted into pMV261-crRNA plasmid, to form plasmid library (method of pMV261-crRNA plasmid construction is shown in embodiment 1).
2. the screening of gene mutation body strain library
Detailed in Example 1
Target gene varies less after plasmid library expands in Escherichia coli as the result is shown, and after tubercle bacillus amplification Variation is then very big, illustrates that library can interfere with the growth indispensable gene (Fig. 6 A and B) of tubercle bacillus.Simultaneously it has also been found that with big Enterobacteria is compared, and library can influence the expression (Fig. 6 C and D) of some genes of tubercle bacillus.These differential genes are analyzed It was found that 208 belong to growth of bacillus tubercle auxiliary gene and 385 growth of bacillus tubercle indispensable genes (Fig. 6 E).At 208 80% gene has been confirmed in growth auxiliary gene, illustrates that this method can be used for the screening of mutant library.Preceding 15% belongs to oxin-antitoxin family, 35% belongs to the gene packet of pressure GAP-associated protein GAP, 10% in 20 growth related genes It is to assume albumen containing zone of ignorance, 15% and 25% is Unknown Function albumen (Fig. 6 F).208 growths of comparative analysis assist base Probiotics genome finds that these gene pairs probiotics have certain side effect, the thermodynamic chart of preceding 31 genes in cause and 43 It shows and the similitude of 43 kinds of probiotics (Fig. 6 G) to the greatest extent.
Other unspecified parts are the prior art.Although above-described embodiment is made that in detail the present invention Description, but it is only a part of the embodiment of the present invention, rather than whole embodiments, people can also exist according to the present embodiment Without other embodiments are obtained under the premise of creativeness, these embodiments belong to the scope of the present invention.
Sequence table
<110>Hua Zhong Agriculture University
<120>endogenous Rv2823c coding albumen is in tubercle bacillus gene insertion, knockout, interference and mutant library screening Using
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 809
<212> PRT
<213>tubercle bacillus H37Rv (Mycobacterium tuberculosis H37Rv)
<400> 1
Met Asn Pro Gln Leu Ile Glu Ala Ile Ile Gly Cys Leu Leu His Asp
1 5 10 15
Ile Gly Lys Pro Val Gln Arg Ala Ala Leu Gly Tyr Pro Gly Arg His
20 25 30
Ser Ala Ile Gly Arg Ala Phe Met Lys Lys Val Trp Leu Arg Asp Ser
35 40 45
Arg Asn Pro Ser Gln Phe Thr Asp Glu Val Asp Glu Ala Asp Ile Gly
50 55 60
Val Ser Asp Arg Arg Ile Leu Asp Ala Ile Ser Tyr His His Ser Ser
65 70 75 80
Ala Leu Arg Thr Ala Ala Glu Asn Gly Arg Leu Ala Ala Asp Ala Pro
85 90 95
Ala Tyr Ile Ala Tyr Asn Ile Ala Ala Gly Thr Asp Arg Arg Lys Ala
100 105 110
Asp Ser Asp Asp Gly His Gly Ala Ser Thr Trp Asp Pro Asp Thr Pro
115 120 125
Leu Tyr Ser Met Phe Asn Arg Phe Gly Ser Gly Thr Ala Asn Leu Ala
130 135 140
Phe Ala Pro Glu Met Leu Asp Asp Arg Lys Pro Ile Asn Ile Pro Ser
145 150 155 160
Pro Arg Arg Ile Glu Phe Asp Lys Asp Arg Tyr Ala Ala Ile Val Asn
165 170 175
Lys Leu Lys Ala Ile Leu Val Asp Leu Glu Arg Ser Asp Thr Tyr Leu
180 185 190
Ala Ser Leu Leu Asn Val Leu Glu Ala Thr Leu Ser Phe Val Pro Ser
195 200 205
Ser Thr Asp Ala Ser Glu Val Val Asp Val Ser Leu Phe Asp His Leu
210 215 220
Lys Leu Thr Gly Ala Leu Gly Ala Cys Ile Trp His Tyr Leu Gln Ala
225 230 235 240
Thr Gly Gln Ser Asp Phe Lys Ser Ala Leu Phe Asp Lys Gln Asp Thr
245 250 255
Phe Tyr Asn Glu Lys Ala Phe Leu Leu Thr Thr Phe Asp Val Ser Gly
260 265 270
Ile Gln Asp Phe Ile Tyr Thr Ile His Ser Ser Gly Ala Ala Lys Met
275 280 285
Leu Arg Ala Arg Ser Phe Tyr Leu Glu Met Leu Thr Glu His Leu Ile
290 295 300
Asp Glu Leu Leu Ala Arg Val Gly Leu Ser Arg Ala Asn Leu Asn Tyr
305 310 315 320
Ser Gly Gly Gly His Ala Tyr Leu Leu Leu Pro Asn Thr Glu Ser Ala
325 330 335
Arg Lys Ser Val Glu Gln Phe Glu Arg Glu Ala Asn Asp Trp Leu Leu
340 345 350
Glu Asn Phe Ala Thr Arg Leu Phe Ile Ala Thr Gly Ser Val Pro Leu
355 360 365
Ala Ala Asn Asp Leu Met Arg Arg Pro Asn Glu Ser Ala Ser Gln Ala
370 375 380
Ser Asn Arg Ala Leu Arg Tyr Ser Gly Leu Tyr Arg Glu Leu Ser Glu
385 390 395 400
Gln Leu Ser Ala Lys Lys Leu Ala Arg Tyr Ser Ala Asp Gln Leu Arg
405 410 415
Glu Leu Asn Ser Arg Asp His Asp Gly Gln Lys Gly Asp Arg Glu Cys
420 425 430
Ser Val Cys His Thr Val Asn Arg Thr Val Ser Ala Asp Asp Glu Pro
435 440 445
Lys Cys Ser Leu Cys Gln Ala Leu Thr Ala Ala Ser Ser Gln Ile Gln
450 455 460
Ser Glu Ser Arg Arg Phe Leu Leu Ile Ser Asp Gly Ala Thr Lys Gly
465 470 475 480
Leu Pro Leu Pro Phe Gly Ala Thr Leu Thr Phe Cys Ser Arg Ala Asp
485 490 495
Ala Asp Lys Ala Leu Gln Gln Pro Gln Thr Arg Arg Arg Tyr Ala Lys
500 505 510
Asn Lys Phe Phe Ala Gly Glu Cys Leu Gly Thr Gly Leu Trp Val Gly
515 520 525
Asp Tyr Val Ala Gln Met Glu Phe Gly Asp Tyr Val Lys Arg Ala Ser
530 535 540
Gly Ile Ala Arg Leu Gly Val Leu Arg Leu Asp Val Asp Asn Leu Gly
545 550 555 560
Gln Ala Phe Thr His Gly Phe Met Glu Gln Gly Asn Gly Lys Phe Asn
565 570 575
Thr Ile Ser Arg Thr Ala Ala Phe Ser Arg Met Leu Ser Leu Phe Phe
580 585 590
Arg Gln His Ile Asn Tyr Val Leu Ala Arg Pro Lys Leu Arg Pro Ile
595 600 605
Thr Gly Asp Asp Pro Ala Arg Pro Arg Glu Ala Thr Ile Ile Tyr Ser
610 615 620
Gly Gly Asp Asp Val Phe Val Val Gly Ala Trp Asp Asp Val Ile Glu
625 630 635 640
Phe Gly Ile Glu Leu Arg Glu Arg Phe His Glu Phe Thr Gln Gly Lys
645 650 655
Leu Thr Val Ser Ala Gly Ile Gly Met Phe Pro Asp Lys Tyr Pro Ile
660 665 670
Ser Val Met Ala Arg Glu Val Gly Asp Leu Glu Asp Ala Ala Lys Ser
675 680 685
Leu Pro Gly Lys Asn Gly Val Ala Leu Phe Asp Arg Glu Phe Thr Phe
690 695 700
Gly Trp Asp Glu Leu Leu Ser Lys Val Ile Glu Glu Lys Tyr Arg His
705 710 715 720
Ile Ala Asp Tyr Phe Ser Gly Asn Glu Glu Arg Gly Met Ala Phe Ile
725 730 735
Tyr Lys Leu Leu Glu Leu Leu Ala Glu Arg Asp Asp Arg Ile Thr Lys
740 745 750
Ala Arg Trp Val Tyr Phe Leu Thr Arg Met Arg Asn Pro Thr Gly Asp
755 760 765
Thr Ala Pro Phe Gln Gln Phe Ala Asn Arg Leu His Gln Trp Phe Gln
770 775 780
Asp Pro Thr Asp Ala Lys Gln Leu Lys Thr Ala Leu His Leu Tyr Ile
785 790 795 800
Tyr Arg Thr Arg Lys Glu Glu Ser Glu
805
<210> 2
<211> 2430
<212> DNA
<213>tubercle bacillus H37Rv (Mycobacterium tuberculosis H37Rv)
<400> 2
atgaacccgc aactcatcga ggccataatc ggctgcctct tgcacgacat tggcaaaccg 60
gtccagcgcg cggcgctcgg ctacccgggc aggcacagtg cgattggccg cgcttttatg 120
aagaaggtgt ggttgcgcga cagccgcaat ccgtcgcagt tcaccgacga ggtggatgag 180
gctgacattg gggtctccga ccgccgcatt ctcgacgcga tcagctatca ccacagttct 240
gcgctgcgta cggcggccga gaatggccgc cttgccgccg atgcgccggc ctacatcgcc 300
tacaatatcg cggccggaac cgaccgccgc aaggccgact ccgacgacgg ccatggtgcg 360
agcacttggg atccggacac gcccctgtat tcgatgttca accgattcgg ctccggcaca 420
gcgaatctgg catttgcccc ggagatgctc gacgaccgca agccgatcaa tataccgtcg 480
ccacgccgga tcgaattcga caaggaccgc tacgccgcca tcgtcaacaa acttaaagcc 540
attctggtcg acctcgaacg ttccgacacc tacctcgcca gcctcctcaa cgtcctcgag 600
gcgacgctgt cgttcgtgcc gtcctcgacc gacgcgtccg aggtcgtcga cgtctcactc 660
ttcgaccacc tgaagctgac gggtgcgctc ggcgcctgca tctggcacta cctacaagcc 720
accggacaaa gcgacttcaa gtcagcgctg ttcgacaagc aggacacctt ctacaacgaa 780
aaagccttcc tgctcacaac tttcgacgtc tcaggcatcc aggacttcat ctacacgatc 840
cattcctcgg gtgccgcgaa gatgctgcgt gcccgcagct tctacctgga gatgctgacc 900
gagcatctca tcgacgagct acttgcgcgg gtgggtctca gccgcgcgaa tctcaactac 960
tccggcggcg ggcacgcgta cctgctgctg cccaacacgg agtccgcgcg gaaatccgtc 1020
gaacagttcg agcgtgaggc caacgactgg ctgctggaaa acttcgcaac ccggctcttc 1080
atcgccacgg gcagcgtacc gcttgccgcg aacgacctga tgcgtcggcc gaacgagagt 1140
gcgagccagg caagtaaccg cgccctccgc tacagcgggc tctaccgtga gttgagcgag 1200
caactttccg cgaagaagct cgcccgatac agcgctgacc aactgcggga actcaactcg 1260
cgcgatcacg acggtcagaa aggtgaccgg gaatgcagcg tgtgccacac ggtcaaccgc 1320
acggtcagcg ccgacgacga gccaaagtgc agcctgtgcc aagcgctgac cgctgcgtct 1380
tcgcagattc aatccgagtc tcgccgcttc ctactcatct ctgacggcgc caccaaaggt 1440
ctgcccctgc cgttcggcgc cacactcacg ttctgtagcc gagccgacgc cgataaggca 1500
ctccagcaac cccaaacccg aaggcggtac gcgaagaaca agttcttcgc cggcgagtgt 1560
ttgggcaccg ggctctgggt gggcgactac gtcgcacaga tggagttcgg tgactacgtg 1620
aagcgtgcga gcggaatcgc gcgcctcggg gttctgcgcc ttgacgtcga taacctgggc 1680
caggcattca cgcacggctt catggagcaa ggcaacggca agttcaacac gattagccgc 1740
acggccgcgt tctcccggat gctgtcgttg ttcttccggc agcacatcaa ctacgtgttg 1800
gcacgcccga aactgcgccc gatcaccggc gatgacccgg cgcggccccg cgaggccacg 1860
atcatctact ccggtggcga tgacgtcttc gtcgtgggcg cgtgggacga cgtcatcgag 1920
ttcgggatcg agcttcggga gcggttccac gaattcaccc agggcaaact caccgtgtcg 1980
gctggcatcg gcatgttccc cgacaagtac cccatctccg tgatggcccg cgaagtcgga 2040
gatctcgaag acgcggcgaa gtcgctgccc ggcaagaacg gggttgcact cttcgatcgc 2100
gagttcacct tcggctggga tgagctgctc agcaaggtga tcgaggagaa gtaccggcac 2160
atcgccgact atttcagtgg caacgaagaa cgcggcatgg ccttcatcta caagctgctc 2220
gaactactcg ccgaacgcga cgatcgaatc acaaaggcca gatgggtgta cttcctcacg 2280
cgcatgcgta accccaccgg tgacacagcg ccttttcagc agtttgctaa ccggctacac 2340
caatggttcc aagatccgac agacgccaag caactcaaga ccgcgctgca cctctacatc 2400
tatcgcactc gcaaggagga gtccgaatga 2430

Claims (8)

1. a kind of endogenous Rv2823c coding albumen carries out gene insertion, knockout or interference in tubercle bacillus and growth is required Application in gene mutation body library screening, wherein the amino acid sequence such as SEQ ID No.1 of endogenous Rv2823c coding albumen It is shown;The nucleotide sequence of endogenous Rv2823c gene is as shown in SEQ ID No.2.
2. application according to claim 1, it is characterised in that: the insertion, the gene for knocking out or interfering are tubercle bacillus Genome in any one or more genes.
3. application according to claim 1, it is characterised in that: still further, the gene is growth indispensable gene.
4. a kind of suitable for the insertion of gene described in claim 1, the recombinant plasmid of knockout or interference editting function, feature exists In: the boot sequence x, x 1,2,3,4 ... containing more than one and tubercle bacillus target gene interaction in the plasmid;Wherein, Boot sequence x is the nucleotide sequence that 40bp is arbitrarily chosen in target-gene sequence.
5. a kind of recombinant plasmid library suitable for growth indispensable gene mutant library screening described in claim 1, feature It is: N number of plasmid in the plasmid library, the boot sequence containing 5658 with tubercle bacillus target gene interaction in all plasmids X, x 1,2,3,4 ...;Wherein, boot sequence is the nucleotide sequence of any 40bp on target gene coding strand.
6. being suitable for the building of autogene insertion, the recombinant plasmid for knocking out or interfering editting function described in a kind of claim 4 Method, it is characterised in that: the following steps are included:
1) repetitive sequence is designed, wherein repetitive sequence repeat is tcgtcagacccaaaaccccgagaggggacggaaac,
2) complex sequences repeat is aggravated at the both ends restriction enzyme site BbsI, synthesis obtains sequence repeat-BbsI-repeat;
3) repeat-BbsI-repeat is inserted into plasmid pMV-261 using the strategy of homologous recombination, that is, forms pMV-261- crRNA;
4) using the DNA sequence dna of any one gene in tubercle bacillus gene group as template, select length for the guidance of 40bp respectively Sequence x;
5) single-stranded boot sequence is made to become double-strand by Gradient annealing,
6) it will be inserted into pMV261 plasmid after the BbsI digestion of double-strand boot sequence, obtain pMV261-gRNA;
It 7) is stencil design upstream and downstream homology arm according to target gene upstream and downstream gene, for the ease of screening, specificity is inserted into EGFP, Obtain upstream homology arm -- the downstream EGFP-- homology arm sequence;Sequence HDR is opened the terminator of upstream homology arm and EGFP's Mover removes, and becomes an ORF;
8) pMV261-gRNA is subjected to digestion with PstI, then connected, form pMV-gRNA-HDR;
9) above-mentioned connection product is converted into stable3 infection state cell, extracts plasmid pMV-gRNA-HDR, then sequencing mirror It is fixed;Obtain recombinant plasmid pMV-gRNA-HDR.
7. a kind of in building insertion, knockout or interfere editor's base using the recombinant plasmid pMV-gRNA-HDR of claim 4 or 6 It is applied in the bacterial strain of cause.
8. a kind of, using recombinant plasmid library is stated described in claim 5, growth of bacillus tubercle is required and dispensable gene being suitable for It is applied in mutant library screening.
CN201910229594.6A 2019-03-25 2019-03-25 Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening Pending CN110117608A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910229594.6A CN110117608A (en) 2019-03-25 2019-03-25 Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910229594.6A CN110117608A (en) 2019-03-25 2019-03-25 Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening

Publications (1)

Publication Number Publication Date
CN110117608A true CN110117608A (en) 2019-08-13

Family

ID=67520613

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910229594.6A Pending CN110117608A (en) 2019-03-25 2019-03-25 Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening

Country Status (1)

Country Link
CN (1) CN110117608A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113136372A (en) * 2021-05-28 2021-07-20 广西大学 Construction method of recombinant phage
CN113981547A (en) * 2021-11-12 2022-01-28 博雅缉因(北京)生物科技有限公司 Method for efficiently constructing sgRNAs plasmid library

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103698512A (en) * 2013-11-25 2014-04-02 广东体必康生物科技有限公司 Application of mycobacterium tuberculosis proteins in preparation of products used for diagnosis of latent tuberculosis infection
WO2017081097A1 (en) * 2015-11-09 2017-05-18 Ifom Fondazione Istituto Firc Di Oncologia Molecolare Crispr-cas sgrna library

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103698512A (en) * 2013-11-25 2014-04-02 广东体必康生物科技有限公司 Application of mycobacterium tuberculosis proteins in preparation of products used for diagnosis of latent tuberculosis infection
WO2017081097A1 (en) * 2015-11-09 2017-05-18 Ifom Fondazione Istituto Firc Di Oncologia Molecolare Crispr-cas sgrna library

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GUAN J等: "Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in Staphylococcus aureus", 《MSPHERE.》 *
RAHMAN K等: "Reprogramming Mycobacterium tuberculosis CRISPR System for Gene Editing and Genome-wide RNA Interference Screening", 《GENOMICS PROTEOMICS BIOINFORMATICS》 *
WEI W等: "Mycobacterium tuberculosis type III-A CRISPR/Cas system crRNA and its maturation have atypical features", 《FASEB J.》 *
郝梦圆等: "CRISPRs基因编辑技术研究进展", 《生物技术通报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113136372A (en) * 2021-05-28 2021-07-20 广西大学 Construction method of recombinant phage
CN113981547A (en) * 2021-11-12 2022-01-28 博雅缉因(北京)生物科技有限公司 Method for efficiently constructing sgRNAs plasmid library

Similar Documents

Publication Publication Date Title
CN114410625B (en) RNA-guided DNA cleavage by Cas9-crRNA complex
WO2017090761A1 (en) Method for converting monocot plant genome sequence in which nucleic acid base in targeted dna sequence is specifically converted, and molecular complex used therein
CN111607594B (en) CRISPR-Cas9 editing technology-based cell line for knocking out pig IRF8 gene and construction method thereof
US5300431A (en) Positive selection vector for the bacteriophage P1 cloning system
CN109022449B (en) Cucumber CsMLO1 gene and construction method and application of silent expression vector thereof
CN108277231B (en) CRISPR system for corynebacterium genome editing
CN104109687A (en) Construction and application of Zymomonas mobilis CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-association proteins)9 system
JPH10304876A (en) Improved recombinant dna molecule
CN106755037A (en) Streptomyces virginiae IBL14 type I-B-sv14 CAS gene editing system
CN108220288B (en) Polynucleotide, transformant and application thereof
CN110117608A (en) Application of the endogenous Rv2823c coding albumen in tubercle bacillus gene insertion, knockout, interference and mutant library screening
CN109234221B (en) Potato X virus attenuated vaccine and preparation method and application thereof
EP2383337B1 (en) Novel promoter for use in transformation of algae
CN113136372B (en) Construction method of recombinant phage
CN110591994B (en) Sodium hydroxide stimulation-based vibrio harveyi homologous recombination gene knockout method
CN116121288B (en) Vector for cloning pseudomonas putida large fragment DNA and application thereof
CN110591993A (en) Vibrio harveyi homologous recombination gene knockout method based on hydrochloric acid stimulation
JP2024509048A (en) CRISPR-related transposon system and its usage
JP2024509047A (en) CRISPR-related transposon system and its usage
CN110066819B (en) Anti-phage and anti-virus system based on DNA (deoxyribonucleic acid) phosphorothioation modification
CN114457071A (en) RNA type toxin commonly used in archaea and bacteria and related biological material thereof
CN109385439A (en) The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis
CN114480464B (en) Double plasmid construction method of vibrio parahaemolyticus CRISPRi
CN112175981A (en) Vibrio harveyi site-directed gene knockout method based on stimulation of absolute ethyl alcohol or sodium dodecyl sulfate
CN117683755B (en) C-to-G base editing system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190813

RJ01 Rejection of invention patent application after publication